|Last Price$0.09||Day Change (%)18.76%|
|Open Price$0.09||Day Change ($)0.01|
|Day Range0.09–0.09||52-Week Range0.07–0.09|
As of Fri 10/16/2015 1:03:00 PM | USD
Merz North America Announces the Appointment of Philippe Adams as Vice President, Managed Markets
Research and Markets: Sustained Release Ocular Drug Delivery Systems Market to Reach USD 6.5 Billion by 2025 - Market Analysis and Forecast 2015 - 2025 (2nd edition)
PanOptica Reports Progress with PAN-90806, a Topical Anti-VEGF Eyedrop for the Treatment of Neovascular (Wet) AMD
The stocks mentioned in this article be holdings in the managed portfolios of Validea Capital Management, a separate asset management firm founded by Validea.com founder John Reese. Validea Capital Management, which an SEC registered investment advisory firm and a separate company from Validea.com, ...
Alcon benefits from leadership positions across eye care.
Four offerings deemed to be right for right now.
The company's diverse operating divisions and robust pipeline should lead to steady growth.
BBH Core Select manager Tim Hartch says focusing on easy-to-understand businesses, particularly in the financials and consumer defensive sectors, helps his team avoid negative surprises.